IndraLab

Statements


MYSM1 inhibits human colorectal cancer tumorigenesis. 1 / 1
| 1

eidos
"MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members / CDH1 and blocking PI3K / AKT signaling ."